Related Experiment Video
Updated: Mar 14, 2026

07:40
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
Published on: May 27, 2021
4.7K
Molecular-Driven Multi-View Hypergraph Contrastive Learning for Drug-Drug Interaction Prediction
Summary
This study introduces Mol-HCL, a novel framework for predicting drug-drug interactions (DDIs) by analyzing internal molecular structures. Mol-HCL significantly improves DDI prediction accuracy by integrating multi-view hypergraph contrastive learning.
Area of Science:
- Computational chemistry
- Bioinformatics
- Pharmacology
Background:
- Drug combinations can cause adverse reactions, necessitating accurate drug-drug interaction (DDI) prediction.
- Existing DDI prediction methods often focus on superficial molecular features, neglecting crucial internal structural information.
Purpose of the Study:
- To propose Mol-HCL, a multi-view hypergraph contrastive learning framework for enhanced DDI prediction.
- To leverage internal molecular structure information for more accurate DDI forecasting.
Main Methods:
- Developed a multi-view hypergraph contrastive learning framework (Mol-HCL) with molecular, structural, and semantic views.
- Incorporated hypernodes and hyperchains to capture complex intra- and inter-molecular relationships.
- Utilized contrastive learning between structural/semantic hypergraphs and the molecular view to refine drug representations.
Main Results:
- Mol-HCL demonstrated significant improvements over existing methods in DDI prediction tasks.
- The framework effectively captures both intra-molecular and inter-molecular information for DDI analysis.
- Experimental validation on two real-world datasets confirmed the efficacy of the proposed approach.
Conclusions:
- Mol-HCL offers a powerful new approach for DDI prediction by analyzing internal molecular structures.
- The multi-view hypergraph contrastive learning strategy enhances the accuracy and robustness of DDI prediction.
- This framework provides valuable insights into potential drug combination risks.
Related Concept Videos
Drug toxicity: Drug–Drug Interaction
223
Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...
223
Drug-Receptor Interactions
8.0K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
8.0K
Quantitative Aspects of Drug-Receptor Interaction
2.1K
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
2.1K
Combined Effects of Drugs: Antagonism
12.0K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
12.0K
Pharmacokinetics: Drug–Drug Interactions
600
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
600
Pharmacodynamic Models: Additive and Proportional Drug Effect Model
51
Drug response models describe how pharmacological agents interact with biological systems to produce measurable effects. Baseline responses are inherent physiological activities without a drug significantly influencing the observed pharmacological outcomes. Depending on the drug response model employed, these baseline responses may combine with the drug's effect in either an additive or proportional manner.Additive Drug Response ModelIn the additive model, the drug effect is independent of the...
51

